For ferroptosis, HNC studies highlight GPX4, SLC7A11, ACSL4, NCOA4, and composite signatures, with a ferroptosis-related gene risk score stratifying HNSCC patients by outcome [64]. This evidence concerns the gene GPX4 and head and neck squamous cell carcinoma.